首页> 美国卫生研究院文献>Evidence-based Complementary and Alternative Medicine : eCAM >Protective Effects of Green Tea Extract against Hepatic Tissue Injury in Streptozotocin-Induced Diabetic Rats
【2h】

Protective Effects of Green Tea Extract against Hepatic Tissue Injury in Streptozotocin-Induced Diabetic Rats

机译:绿茶提取物对链脲佐菌素诱导的糖尿病大鼠肝组织损伤的保护作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Although diabetic hepatopathy is potentially less common, it may be appropriate for addition to the list of target organ conditions related to diabetes. This study was designed to evaluate the hepatoprotective properties of green tea extract (GTE) in STZ-induced diabetes in rats. Wistar rats were made diabetic through single injection of STZ (75 mg/kg i.p.). The rats were randomly divided into four groups of 10 animals each: Group 1, healthy control; Group 2, nondiabetics treated with GTE administered orally (1.5%, w/v); Group 3, diabetics; Group 4, diabetics treated with GTE (1.5%, w/v) for 8 weeks. Serum biomarkers were assessed to determine hepatic injury. Malondialdehyde (MDA) and reduced glutathione (GSH) contents were measured to assess free radical activity in the liver tissue. Hepatic antioxidant activities of glutathione peroxidase (GSH-Px), superoxide dismutase (SOD), and catalase (CAT) were also determined. The biochemical findings were matched with histopathological verifications. Liver MDA content and serum levels of ALT, AST, ALP, and bilirubin in Group 3 significantly increased compared to Group 1 (P < 0.05) and significantly decreased in Group 4 compared to Group 3 (P < 0.05). Serum albumin level and GSH, SOD, CAT, and GSH-Px contents of the liver in Group 3 were significantly decreased compared to Group 1 (P < 0.05) and were significantly increased in Group 4 compared to Group 3 (P < 0.05). Histopathologically, the changes were in the same direction with biochemical findings. This study proved the hepatoprotective activity of GTE in experimentally induced diabetic rats.
机译:尽管糖尿病性肝病​​可能不太常见,但可能适合添加到与糖尿病有关的目标器官疾病中。这项研究旨在评估绿茶提取物(GTE)在STZ诱导的大鼠糖尿病中的肝保护特性。通过单次注射STZ(75μmg/ kg i.p.)使Wistar大鼠患上糖尿病。将大鼠随机分为四组,每组10只动物:第1组,健康对照组;第1组,健康对照组。第2组,口服GTE治疗的非糖尿病患者(1.5%,w / v);第3组,糖尿病患者;第4组糖尿病患者接受GTE(1.5%,w / v)治疗8周。评估血清生物标志物以确定肝损伤。测量丙二醛(MDA)和还原型谷胱甘肽(GSH)含量以评估肝脏组织中的自由基活性。还测定了谷胱甘肽过氧化物酶(GSH-Px),超氧化物歧化酶(SOD)和过氧化氢酶(CAT)的肝抗氧化活性。生化结果与组织病理学证实相符。与第1组相比,第3组的肝脏MDA含量和ALT,AST,ALP和胆红素的血清水平显着高于第1组(P <0.05),而第4组与第3组相比则显着降低(P <0.05)。与第1组相比,第3组的血清血清白蛋白水平和肝脏GSH,SOD,CAT和GSH-Px含量显着降低(P <0.05),与第3组相比,第4组显着升高(P <0.05)。在组织病理学上,这些变化与生化发现方向相同。这项研究证明了GTE在实验诱导的糖尿病大鼠中的肝保护活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号